Pipeline Noticeocds-b5fd17-76fe727e-9816-4a66-bc9c-c1acb016e466
Specialised - Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema
Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema
Buyer
NHS ENGLAND
Value
£15,000,000
Published
13 Dec 2019
Closes
13 Dec 2019
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default Specialised - Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema
£15,000,000
Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkFuture opportunity notice on Contracts Finder
13 Dec 2019
Future opportunity notice on Contracts Finder
Planned procurement notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.